India vs Senegal: Cause of death, by non-communicable diseases, ages 15-59
India
46.3%
in 2021
Senegal
46.3%
in 2021
India rank
121st
Senegal rank
120th
Cause of death, by non-communicable diseases, ages 15-59 over time
- India
- Senegal
How they compare
Senegal currently reports 46.3% against 46.3% in India, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Senegal ahead.
India ranks 121st and Senegal ranks 120th of 185 countries.
Across the 3 decades both report, India averaged higher in 2 and Senegal in 1.
Head to head by decade
| Decade | India | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.4% | 42.1% | 0.7% | Senegal |
| 2010s | 58.3% | 50.1% | 8.2% | India |
| 2020s | 52.7% | 48.4% | 4.3% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, India or Senegal?
- Senegal, at 46.3% against 46.3% in India as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between India and Senegal?
- 0.0%, with Senegal ahead.
- How many years of comparable data are there for India and Senegal?
- 6 years are reported by both, from 2000 to 2021.
- How do India and Senegal rank globally for cause of death, by non-communicable diseases, ages 15-59?
- India ranks 121st and Senegal ranks 120th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.